Fisher & Paykel Healthcare Corporation Limited (FPH), a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea, has provided revenue guidance for the financial year ending 31 March 2022.
Revenue is expected to be in the range of $1.675 billion to $1.70 billion and the company intends to release its financial results for the year on Wednesday, 25 May 2022.
See more
